Discover investment opportunities in Therapeutic Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Therapeutic Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Therapeutic Stocks using our Smart AI Filter.
10 stocks found for "Therapeutic Stocks"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
0.45 Risk measure | ±25.0% Price volatility | 14.4 Valuation | 3.19% Annual yield | |||
0.34 Risk measure | ±25.2% Price volatility | 8.0 Valuation | 0.00% Annual yield | |||
0.60 Risk measure | ±39.2% Price volatility | 20.8 Valuation | 0.00% Annual yield | |||
0.62 Risk measure | ±41.3% Price volatility | -11.5 Valuation | 0.00% Annual yield | |||
0.61 Risk measure | ±31.4% Price volatility | 19.2 Valuation | 0.00% Annual yield | |||
0.30 Risk measure | ±26.0% Price volatility | 12.1 Valuation | 0.66% Annual yield | |||
0.22 Risk measure | ±27.3% Price volatility | 15.0 Valuation | 2.83% Annual yield | |||
0.36 Risk measure | ±26.9% Price volatility | 24.5 Valuation | 0.00% Annual yield | |||
0.70 Risk measure | ±46.8% Price volatility | 1.5 Valuation | 0.00% Annual yield | |||
1.06 Risk measure | ±44.4% Price volatility | -272.1 Valuation | 0.00% Annual yield |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Q: How does dividend income potential of therapeutic stocks like 9JNJ 9 and 6ABBV 9 compare to other sectors?
A: Therapeutic stocks like JNJ and ABBV are noted for their consistent dividend payouts, appealing to income-focused investors. Historically, these companies have maintained stable dividends due to robust earnings in healthcare. However, investors should assess payout ratios and company-specific financial health to gauge future dividend sustainability.
Q: What are some sector-specific risks for biotech companies like 1GILD 1 and 1VRTX 1?
A: Companies like GILD and VRTX face risks including high R&D costs, regulatory challenges, and significant reliance on pipeline products. Shifts in healthcare reimbursement policies and competition from generics or biosimilars also pose substantial risks, necessitating thorough examination of each company's research and development pipeline.
Q: How do stocks like 1MRK 1 and 1BMY 1 behave during economic downturns?
A: Stocks like MRK and BMY typically exhibit lower volatility compared to broader markets during downturns. Their products, especially essential medications, maintain demand independent of economic conditions, providing them with a degree of financial stability. Investors often consider such companies a defensive play in uncertain markets.
Q: What geographic markets are influenced by companies like 1PFE 1 and 1LLY 1?
A: PFE and LLY have a substantial global presence with operations across North America, Europe, and emerging markets. These companies could be significantly impacted by international regulatory environments and currency exchange rates. Investors should monitor these factors as they can influence revenue and growth potential.
Q: How do innovations and patent expirations affect therapeutic stocks such as 1REGN 1 and 1AMGN 1?
A: Innovation in drug development can boost revenues and market position for REGN and AMGN. However, patent expirations pose a risk by potentially decreasing revenue as generic competition increases. Monitoring each company's pipeline and patent portfolio is essential to understanding potential financial impacts.
Q: Are therapeutic stocks like 1JNJ 1 and 1ABBV 1 considered growth or value investments?
A: JNJ and ABBV can be seen as hybrid stocks, providing both value and growth potential. They possess stable earnings with a history of steady dividends, signaling value qualities, while also engaging in innovative therapies and acquisitions to drive growth. Investors typically assess individual company strategies and financials.
The consensus price target hints at a 70.8% upside potential for BioMarin (BMRN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Read moreIonis Pharmaceuticals (IONS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Read moreInvestors with an interest in Medical - Drugs stocks have likely encountered both Catalyst Pharmaceutical (CPRX) and Neurocrine Biosciences (NBIX). But which of these two stocks offers value investors a better bang for their buck right now?
Read more